Top

Published in:

01-06-2023 | Dronabinol | News item

Harvard Drug Group label mix-up: dronabinol and ziprasidone capsules recalled

Published in: Reactions Weekly | Issue 1/2023

Excerpt

The US FDA has reported an announcement from the Harvard Drug Group that it has issued a nationwide recall of one lot of dronabinol 2.5mg capsules and ziprasidone 20mg capsules due to a label mix-up. …

The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg Due to Label Mix-up Internet Document : 14 Jun 2023. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/harvard-drug-group-llc-issues-voluntary-nationwide-recall-dronabinol-capsules-usp-25-mg-and

Title: Harvard Drug Group label mix-up: dronabinol and ziprasidone capsules recalled
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keywords: Dronabinol
Ziprasidone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41672-0

At a glance: The STEP trials

Springer Medicine

Harvard Drug Group label mix-up: dronabinol and ziprasidone capsules recalled

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Cisplatin

Multiple drugs

Multiple drug

Vismodegib

Afatinib/cisplatin/gemcitabine